Prevalence of anxiety disorders and its co-occurrence with substance use disorder: a clinical study

Middle East Current Psychiatry

Table 4 Correlations between anxiety disorders and different substances used by patients with substance use disorder

		Crystal	Cannabis	Opium	Heroin	Methadone	Tramadol	Alcohol	LSD	Benzodiazepine	Tobacco
PD^a	p value	0.900	0.047	0.667	0.081	0.563	0.000	0.058	0.001	0.744	0.875
PD^a	r	0.007	0.116	0.025	0.102	0.034	0.205	0.111	0.197	0.019	0.009
Agoraphobia	p value	0.658	0.425	0.682	0.207	0.771	0.503	0.550	0.320	0.580	0.913
Agoraphobia	r	0.026	− 0.047	0.024	0.074	0.017	0.039	− 0.035	0.058	0.033	0.007
SAD^b	p value	0.184	0.035	0.001	0.380	0.010	0.000	0.023	0.036	0.004	0.398
SAD^b	r	0.078	0.124	0.186	0.052	0.152	0.258	0.133	0.123	0.168	− 0.051
GAD^c	p value	0.516	0.423	0.072	0.229	0.954	0.057	0.810	0.213	0.710	0.786
GAD^c	r	0.038	− 0.047	− 0.106	0.071	− 0.003	0.112	0.014	0.073	0.022	0.016